Amgen, Zai Lab team up on DLL3; Janux gets $35M milestone paymentnews2026-04-01T15:26:47+00:00April 1st, 2026|Endpoints News|
Takeda cuts 600+ US jobs; United’s stock rises on Tyvaso datanews2026-03-30T15:01:45+00:00March 30th, 2026|Endpoints News|
AnaptysBio spins out biotech operations; Affibody’s data in hidradenitis suppurativanews2026-03-27T15:33:54+00:00March 27th, 2026|Endpoints News|
Kodiak’s Phase 3 eye drug success; Innate discontinues anti-CD20 programnews2026-03-26T14:28:58+00:00March 26th, 2026|Endpoints News|
Novo reports more triple-G data from China; Grifols plots IPO for biopharma unitnews2026-03-25T14:32:11+00:00March 25th, 2026|Endpoints News|
Karyopharm’s mixed myelofibrosis data; Rezolute to seek FDA approval despite trial failurenews2026-03-24T14:23:33+00:00March 24th, 2026|Endpoints News|
Dizal’s first-line lung cancer data; Sanofi expands in Chinanews2026-03-23T14:01:38+00:00March 23rd, 2026|Endpoints News|
Sarepta to ask FDA for full approval of exon skipping drugs; Rhythm’s label expansion in rare form of obesitynews2026-03-20T15:21:54+00:00March 20th, 2026|Endpoints News|
Ionis delays prion disease readout; Arvinas’ Parkinson’s biomarker datanews2026-03-18T14:17:05+00:00March 18th, 2026|Endpoints News|
Pfizer’s next-gen breast cancer data; Bristol Myers’ PRMT5 candidatenews2026-03-17T14:24:48+00:00March 17th, 2026|Endpoints News|
